TCL Archive Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women November 26, 2010
TCL Archive Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study March 30, 2007
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005